Semaglutide
Consumer Services · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
88 Inverness Cir E Ste 1-204, Englewood,...Phone Number
(303) 790-8446Website
www.semaglutidecolorado.comRevenue
<$5 MillionIndustry
About Semaglutide
Is Semaglutide your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Semaglutide recently announced quarterly report
Semaglutide, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Semaglutide is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Semaglutide has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Semaglutide has recently received funding, and reach out quickly before it becomes old news!
Click to see if Semaglutide had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Semaglutide
Product Launch: Get notified when Semaglutide launches new products
Recommended Actions
Find VP level buyers at Semaglutide
Find 3 more new buyers
Compare Similar Companies to Semaglutide
Compare insights from companies similar to Semaglutide, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Semaglutide
Company Profile Activity
Activity Insights
Semaglutide is experiencing very low activity levels compared to other companies in the Consumer Services sector.
What does this means?
Semaglutide is drawing exceptional interest within the Consumer Services industry, suggesting notable developments or strong market momentum, learn more about Semaglutide.
Semaglutide Tech Stack
A closer look at the technologies used by Semaglutide
Semaglutide News & Media
MEDVi Unveiled: How the Doctor-Led MEDVi GLP-1 Program Is Democratizing Weight Loss with Compounded Semaglutide & Tirzepatide
MEDVi 2025 offers a doctor-led GLP-1 weight loss program with affordable compounded Semaglutide & Tirzepatide — safe, effective, and accessible telehealth care. MEDVi 2025 offers a doctor-led GLP-1 weight loss program with affordable compounded Semaglutide & Tirzepatide — safe, effective, and accessible telehealth care.Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management. In this 2025 availability update, Remote Pharmacy highlights the expanded accessMEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss
A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via Telehealth A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthHims & Hers Super Bowl Ad for Semaglutide "Nothing Short of Reckless," Says Partnership ...
In letters to the FDA and Fox Broadcasting, PSM enumerated the laws abrogated and the potential harms of the ad being viewed by 200 million people on February 9, 2025.
Top Consumer Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Semaglutide
Semaglutide is a company that operates in the Consumer Services industry. It employs 20to49 people and has 1Mto5M of revenue. The company is headquartered in Englewood, Colorado.... Read More